Format

Send to

Choose Destination
Parasitol Today. 1999 Apr;15(4):136-40.

The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes.

Author information

1
Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, UK. m.barrett@bio.gla.ac.uk

Abstract

Resistance to currently used drugs is a serious problem in most fields of antimicrobial chemotherapy. Crossresistance between two of the major classes of drug used in the treatment of African trypanosomiasis, the melaminophenyl arsenicals and diamidines is easily selected in the laboratory. Here, Mike Barrett and Alan Fairlamb outline the mechanism underlying this crossresistance, which appears to arise as a result of alterations in an unusual adenosine transporter involved in the uptake of these drugs.

PMID:
10322334
DOI:
10.1016/s0169-4758(99)01414-3
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center